WNT3 and hepatocellular carcinoma: Potential mechanisms involved in activation of β-catenin in HCC include CTNNB1, AXIN and APC somatic mutations, FZD7 and WNT3 overexpression, SFRP1 and SFRP5 repression [7,68].